Skip to main content
SpringerLink
Log in
Book cover

PET/CT in Gynecological Cancers pp 57–61Cite as

18F-FDG and Non-FDG PET Radiopharmaceuticals

  • Chapter
  • First Online:

  • 855 Accesses

Part of the book series: Clinicians’ Guides to Radionuclide Hybrid Imaging ((PET/CT))

Abstract

Positron emission tomography/computed tomography (PET/CT) is one of the key imaging techniques in oncology. Hybrid PET/CT provides both structural and metabolic information and in general improves sensitivity, specificity and reporter confidence.

The original version of this chapter was revised: The erratum to this chapter is available at DOI 10.1007/978-3-319-29249-6_11

An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-3-319-29249-6_11

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Torizuka T, Tamaki N, Inokuma T, et al. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med. 1995;36:1811–7.

    CAS  PubMed  Google Scholar 

  2. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18F-FDG PET scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308–14.

    Article  CAS  PubMed  Google Scholar 

  3. Warburg O. On the origin of cancer cells. Science. 1956;123:309–14.

    Article  CAS  PubMed  Google Scholar 

  4. Cook GJ, Maisey MN, Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18F-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med. 1999;26:1363–78.

    Article  CAS  PubMed  Google Scholar 

  5. Culverwell AD, Scarsbrook AF, Chowdhury FU. False-positive uptake on 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging. Clin Radiol. 2011;66:366–82.

    Article  CAS  PubMed  Google Scholar 

  6. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61–77.

    Article  CAS  PubMed  Google Scholar 

  7. Delbeke D, Coleman RE, Guiberteau MJ, et al. Procedure guideline for tumour Imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885–95.

    PubMed  Google Scholar 

  8. Boellaard R, O’Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181–200.

    Article  PubMed  Google Scholar 

  9. Segall G, Delbeke D, Stabin MG, et al. SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med. 2010;51:1813–20.

    Article  PubMed  Google Scholar 

  10. Virgolini I, Ambrosini V, Bomanji JB, et al. Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging. 2010;37:2004–10.

    Article  PubMed  Google Scholar 

  11. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;2(354):496–507.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Imaging Sciences, King’s College London, London, UK

    James Ballinger

  2. Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, London, UK

    Gopinath Gnanasegaran

Authors
  1. James Ballinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gopinath Gnanasegaran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James Ballinger .

Editor information

Editors and Affiliations

  1. Imperial College Healthcare NHS Trust, London, United Kingdom

    Tara Barwick

  2. Department of Surgery and Cancer, Imperial College, London, United Kingdom

    Andrea Rockall

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ballinger, J., Gnanasegaran, G. (2016). 18F-FDG and Non-FDG PET Radiopharmaceuticals. In: Barwick, T., Rockall, A. (eds) PET/CT in Gynecological Cancers. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-29249-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29249-6_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29247-2

  • Online ISBN: 978-3-319-29249-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation